Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-141672
Filing Date
2024-12-31
Accepted
2024-12-31 17:49:34
Documents
1
Period of Report
2024-12-18

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3674
  Complete submission text file 0000950170-24-141672.txt   5241
Mailing Address RIVER OAKS TOWER 8800 HSC PARKWAY BYRAN TX 77807
Business Address
Kropotova Alexandra (Reporting) CIK: 0001825323 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39871 | Film No.: 241594001

Mailing Address 777 W 41ST ST SUITE 401 MIAMI BEACH FL 33140
Business Address 777 W 41ST ST SUITE 401 MIAMI BEACH FL 33140 305-845-2813
SAB Biotherapeutics, Inc. (Issuer) CIK: 0001833214 (see all company filings)

EIN.: 853899721 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)